Moderna says its vaccine is 100% effective in kids 12+

Moderna joins Pfizer and Johnson & Johnson in the race to vaccinate America's kids

LINCOLN, Neb. (KLKN)- The COVID-19 vaccine manufacturer, Moderna, has announced its vaccine is 100% effective in children ages 12 to 17, the company said on Tuesday when they announced the results of their latest clinical trials.

According to Moderna, the vaccine showed “no significant safety concerns” in a trial of over 3,700 adolescent participants. The vaccine manufacturer says it plans to submit the trial’s results to U.S. regulators and request authorization in early June.

SEE ALSO: CDC monitoring possible COVID vaccine side effect in teens

“We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents. It is particularly exciting to see that the Moderna COVID-19 vaccine can prevent SARS-CoV-2 infection,” Moderna CEO Stéphane Bancel said in a statement. “We remain committed to doing our part to help end the COVID-19 pandemic.”

Earlier this month in the U.S., COVID-19 vaccine eligibility was widened to include kids ages 12 and up when the FDA authorized the Pfizer vaccine for this group.

Pfizer is conducting vaccine trials with children as young as 6 months old right now, and the company says it intends on seeking an emergency use authorization for its vaccine for children ages 2 to 11 in September.

Categories: Coronavirus, News